Discovery of BAY-390, a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1)

Stefanie Mesch1, Daryl Walter2, Alexis Laux-Biehlmann3

  • 1Pharmaceutical R&D, Drug Discovery, Medicinal Chemistry, Bayer AG, Müllerstr. 178, 13353 Berlin, Germany.